Senti Biosciences, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

IGC Pharma, Inc.

Pluri, Inc.

OncoCyte Corp.

Pieris Pharmaceuticals, Inc.

Forte Biosciences, Inc.

Equillium, Inc.

Senti Biosciences, Inc.

Cyclo Therapeutics, Inc.

Sensei Biotherapeutics, Inc.

Seelos Therapeutics, Inc.

Rain Oncology, Inc.

Why is Senti Biosciences, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Senti Biosciences, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Senti Biosciences, Inc.

-77.03%

-0.86

100.03%

S&P 500

21.51%

1.63

13.19%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-68.70%

EBIT Growth (5y)

-264.01%

EBIT to Interest (avg)

-44.58

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.77

Sales to Capital Employed (avg)

0.02

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

25.84%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.72

EV to EBIT

-0.15

EV to EBITDA

-0.16

EV to Capital Employed

-1.76

EV to Sales

9.68

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-1008.87%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

NET SALES(9M)

At USD 0.04 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Highest at USD -36.88 MM

NET PROFIT(HY)

Higher at USD -20.52 MM

OPERATING PROFIT(Q)

Highest at USD -10.81 MM

EPS(Q)

Highest at USD -0.14

-2What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 420,000% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 397.89 %

Here's what is working for Senti Biosciences, Inc.

Net Sales

At USD 0.04 MM has Grown at inf%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (USD MM)

Operating Cash Flow

Highest at USD -36.88 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -20.52 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Profit

Highest at USD -10.81 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

EPS

Highest at USD -0.14

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for Senti Biosciences, Inc.

Debt-Equity Ratio

Highest at 397.89 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 420,000% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales